XML 35 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Trade Discounts and Rebates
12 Months Ended
Dec. 31, 2022
Valuation And Qualifying Accounts Disclosure [Line Items]  
Accrued Expenses and Other Current Liabilities

NOTE 9 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities as of December 31, 2022 and 2021 consisted of the following (in thousands):

 

 

As of December 31,

 

 

 

2022

 

 

2021

 

Payroll-related expenses

 

$

121,066

 

 

$

147,439

 

Accrued royalties

 

 

106,126

 

 

 

108,215

 

R&D and manufacturing programs

 

 

66,725

 

 

 

54,076

 

Consulting and professional services

 

 

28,915

 

 

 

33,334

 

Allowances for returns

 

 

28,347

 

 

 

33,881

 

Accrued interest

 

 

15,130

 

 

 

14,989

 

Accrued upfront and milestone payments

 

 

15,000

 

 

 

35,100

 

Refund liability (1)

 

 

12,218

 

 

 

16,711

 

Advertising and marketing

 

 

12,030

 

 

 

16,930

 

Pricing review liability

 

 

 

 

 

21,075

 

Accrued other

 

 

52,000

 

 

 

41,265

 

Accrued expenses and other current liabilities

 

$

457,557

 

 

$

523,015

 

(1)
The refund liability represents the amount of consideration that the Company may need to refund to MTPC if it does not sell the product that was shipped to MTPC. The refund liability is remeasured at each reporting date to reflect changes in the estimate of variable consideration, with a corresponding adjustment to revenue. Amounts expected to be settled within the 12 months following the balance sheet date are classified as current liabilities in the accompanying balance sheets. Amounts not expected to be settled within the 12 months following the consolidated balance sheet date are classified as long-term liabilities. The following represents the changes to the refund liability for the year ended December 31, 2022 (in thousands):

Refund liability at December 31, 2021

$

16,711

 

Shipments during the year ended December 31, 2022

 

14,892

 

Remeasurement of refund liability recognized as revenue

 

(11,194

)

Refund liability at December 31, 2022

$

20,409

 

Less: current portion

 

12,218

 

Refund liability, net of current portion

$

8,191

 

Accrued Trade Discounts and Rebates [Member]  
Valuation And Qualifying Accounts Disclosure [Line Items]  
Accrued Expenses and Other Current Liabilities

NOTE 10 – ACCRUED TRADE DISCOUNTS AND REBATES

Accrued trade discounts and rebates as of December 31, 2022 and 2021 consisted of the following (in thousands):

 

 

As of December 31,

 

 

 

2022

 

 

2021

 

Accrued government rebates and chargebacks

 

$

235,216

 

 

$

222,632

 

Accrued commercial rebates and wholesaler fees

 

 

39,965

 

 

 

48,761

 

Accrued co-pay and other patient assistance

 

 

44,599

 

 

 

46,038

 

Accrued trade discounts and rebates

 

$

319,780

 

 

$

317,431

 

Invoiced commercial rebates and wholesaler fees,
   co-pay and other patient assistance, and government
   rebates and chargebacks in accounts payable

 

 

77,350

 

 

 

 

Total customer-related accruals and allowances

 

$

397,130

 

 

$

317,431

 

 

The following table summarizes changes in the Company’s customer-related accruals and allowances during the years ended December 31, 2022 and 2021 (in thousands):

 

 

Government Rebates and Chargebacks

 

 

Commercial Rebates and Wholesaler Fees

 

 

Co-Pay and Other Patient Assistance

 

 

Total

 

Balance at December 31, 2020

 

$

172,893

 

 

$

84,098

 

 

$

96,924

 

 

$

353,915

 

Current provisions relating to sales during the year ended December 31, 2021

 

 

756,222

 

 

 

282,005

 

 

 

604,209

 

 

 

1,642,436

 

Adjustments relating to prior-year sales

 

 

(21,077

)

 

 

(2,921

)

 

 

(4,516

)

 

 

(28,514

)

Payments relating to sales during the year ended
December 31, 2021

 

 

(538,086

)

 

 

(233,314

)

 

 

(558,182

)

 

 

(1,329,582

)

Payments relating to prior-year sales

 

 

(148,731

)

 

 

(81,177

)

 

 

(92,408

)

 

 

(322,316

)

Viela acquisition on March 15, 2021

 

 

1,411

 

 

 

70

 

 

 

11

 

 

 

1,492

 

Balance at December 31, 2021

 

$

222,632

 

 

$

48,761

 

 

$

46,038

 

 

$

317,431

 

Current provisions relating to sales during the year ended December 31, 2022

 

 

823,299

 

 

 

195,937

 

 

 

345,430

 

 

 

1,364,666

 

Adjustments relating to prior-year sales

 

 

(30,405

)

 

 

2,118

 

 

 

(3,497

)

 

 

(31,784

)

Payments relating to sales during the year ended
December 31, 2022

 

 

(529,311

)

 

 

(153,462

)

 

 

(290,028

)

 

 

(972,801

)

Payments relating to prior-year sales

 

 

(190,657

)

 

 

(47,195

)

 

 

(42,530

)

 

 

(280,382

)

Balance at December 31, 2022

 

$

295,558

 

 

$

46,159

 

 

$

55,413

 

 

$

397,130